Sheel Biotech Limited IPO
Sheel Biotech Limited (“SBL”) was incorporated as Sheel Biotech Private Limited on November 26, 1991, is engaged in growing, developing, processing, and supplying plants for field crops, fruits, vegetables, and ornamental plants using tissue culture and organic farming techniques. The company also manufactures and maintains greenhouses, provides farmer training through Farmer Producer Organizations (FPOs), and delivers green landscaping services to government and private clients.
Business Segments
1. Tissue Culture Segment: Uses totipotency-based technology to produce plants in a sterile, controlled environment. The Manesar lab, equipped with Dutch technology, has a capacity of 10 million plants per year, supplying both public and government clients.
2. Organic Segment: Focused on organic farming practices and certification for agricultural produce.
3. Planting & Landscaping Segment: Provides green landscaping solutions for private and government projects.
4. Skill & FPO Segment: Operates 50 Farmer Producer Organizations to train farmers and enhance agricultural productivity.
5. Green & Packhouse Segment: Supports post-harvest processing, packaging, and logistics for horticultural products.
Geographical Presence
Headquartered in Delhi, SBL has operations across multiple Indian states, including Assam, Andhra Pradesh, Delhi, Haryana, Telangana, Odisha, Uttar Pradesh and Bihar
Competitive Strengths
i) Over 30 Years of Expertise in plant tissue culture and organic farming.
ii) Strong collaborations with plant breeders in the USA, Europe, and Asia.
iii) Expertise in import procedures, plant quarantine, and global tissue culture operations.
iv) Advanced training for technical experts in India and abroad.
v) Proven track record in managing potato seed tissue culture in Eritrea.
vi) Extensive FPO network supporting agricultural development and organic certification.
Objects of the Sheel Biotech Limited IPO:
Sheel Biotech Limited IPO Details:
Open Date: | Sep 30 2025 |
Close Date: | Oct 03 2025 |
Total Shares: | 54,00,000 |
Face Value: | ₹ 10 Per Equity Share |
Issue Type: | Book Building |
Issue Size: | 34.02 Cr. |
Lot Size: | 2000 Shares |
Issue Price: | ₹ 59-63 Per Equity Share |
Listing At: | NSE Emerge |
Listing Date: | Oct 08 2025 |
Promoters And Management:
Financials of Sheel Biotech Limited IPO:
Particulars (Cr) | FY2024-2025 | FY 2023-2024 | FY 2022-2023 |
Revenue from Operations | 101.75 | 92.28 | 80.11 |
EBITDA | 14.97 | 14.45 | 8.82 |
EBITDA Margins | 14.71% | 15.56% | 11.02% |
PAT | 10.63 | 10.47 | 5.07 |
PAT Margins | 10.45% | 11.32% | 6.33% |
ROCE | 16.34% | 16.48% | 10.75% |
Debt to Equity Ratio(In Times) | 0.21 | 0.32 | 0.3 |
Operating Cash Flows | 9.2 | -0.91 | 9.29 |
Comparison With Peers:
Companies | Revenue (in cr) | EBITDA Margins | PAT Margins | ROCE | D/E Ratio | MCap (in cr) | P/E |
Sheel Biotech Limited | 101.75 | 14.71% | 10.45% | 16.34% | 0.21 | 128.22 | 12.06 |
Jain Irrigation System Limited | 5732 | 13% | 0.45% | 0.61% | 0.71 | 3,765.0 | 111 |
Vrundavan Plantation Limited | 25.52 | 10.04% | 6.90% | 10.40% | 0.12 | 27.8 | 15.8 |
Lead Manager of Sheel Biotech Limited IPO:
Registrar of Sheel Biotech Limited IPO:
Discussion on Sheel Biotech Limited IPO:
Leave a Reply
You must be logged in to post a comment.